Article Text

Download PDFPDF
Myotonic dystrophy: a cause of acute breathlessness not to be missed
  1. Caroline Kramarz1,
  2. Abigail Turner2,
  3. Vafa Alakbarzade2,
  4. Brendan Mclean2
  1. 1 Neurology, Queen’s Medical Centre, Nottingham University Hospital NHS Trust, Nottingham, UK
  2. 2 Neurology, Royal Cornwall Hospitals NHS Trust, Truro, UK
  1. Correspondence to Caroline Kramarz, Department of Neurology, Nottingham University Hospitals NHS Foundation Trust; caroline.kramarz{at}nhs.net

Abstract

Myotonic dystrophy type 1 (DM1), the most common muscular dystrophy in adults, is an autosomal dominant disorder with a wide phenotypic spectrum ranging from oligosymptomatic forms to a life-threatening, multisystem disease. People with DM1 overall have a reduced life expectancy, mainly due to respiratory or cardiac causes. There is no cure but prompt, appropriate symptom management is essential to limit disease-related complications. We present a case of DM1, unrecognised when the patient presented with recurrent type 2 respiratory failure, and initially misdiagnosed as Guillain-Barré syndrome. This misdiagnosis subsequently led to unnecessary investigation and treatment before further detailed neurological examination and collateral family history gave the diagnosis. This case highlights the importance of considering a chronic neuromuscular disorder in patients presenting with acute respiratory failure and an unusual pattern of weakness.

  • Myotonic dystrophy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors CK, AT and VA wrote the manuscript, CK, VA and BM reviewed, edited and approved the final version of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Consent obtained directly from patient(s).

  • Provenance and peer review Not commissioned. Externally peer reviewed by Jon Walters, Swansea, UK.

Linked Articles

  • Editors’ commentary
    Phil E M Smith Geraint N Fuller

Other content recommended for you